Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN
09140-cover-BiopharmaProduktionKundlcxd.jpg

October 7, 2013 Cover

Volume 91, Issue 40

Engineering biosimilars, or near copies, of leading biologic drugs, pushes the limits of bioprocessing know-how

Cover image:

Credit:

Full Article
Volume 91 | Issue 40

All Issues

Pharmaceuticals

The New Copycats

Engineering biosimilars, or near copies, of leading biologic drugs, pushes the limits of bioprocessing know-how

  • AstraZeneca’s Experiment

    Firm hopes a move to Europe’s largest biotech community, Cambridge, will boost its anemic drug pipeline

  • EPA Tries Capping Power Plant Carbon

    First-time CO2 limits proposed for new coal or gas-fired plants

ADVERTISEMENT
image name
Physical Chemistry

Laser-Driven Chip Points To Mini Particle Accelerator

Electrons are accelerated in microchips at rates 10 times as high as conventional particle accelerators

ADVERTISEMENT
ADVERTISEMENT